HR 2269/S 1092, WIPPES Act (product labeling for non-flushable wipes); H.R. 2853 / S. 1404,Combating Organized Retail Crime Act; H.R. 4433, Toxic-Free Beauty Act; H.R. 9594 No PFAS In Cosmetics Act; H.R. 6832, Packaging and Claims Knowledge (PACK) Act of 2025; H.R. 7205Recycled Materials Attributions Act.
HR 1657, Humane Cosmetics Act; H.R. 2821/S. 355, FDA Modernization Act 3.0 (issues related to animal-based testing for OTC products); Adoption of non-animal test methods/New Approach Methodologies (NAMs)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations (cosmetic regulation funding issues); Fiscal Year 2027 Appropriations package (funding for the Department of Defense's Melanoma Research Program).
Over-the-Counter Monograph User Fees (issues related to the OMUFA program); Implementation of provision from the Supporting Accessible, Flexible, and Effective (SAFE) Sunscreen Standards Act;
Section 301, Section 232 and IEEPA Tariffs
SHOP SAFE Act (issues related to counterfeit cosmetic products); H.R. 4390: To expand the sharing of information with respect to suspected violations of intellectual property rights in trade (issues related to counterfeit cosmetic products).
US Mexico Canada Agreement Review; Trade issues with China.